Drugs

A recent study has unveiled a new osteoporosis drug under development. However, the direction the researchers are taking closely resembles an existing osteoporosis drug: Evenity (romosozumab). The researchers promote their … Continue Reading →

This month’s bulletin starts off with a warning. Medical researchers have announced the development of yet another osteoporosis drug. We’ll look at the details and what to expect. Then we’ll … Continue Reading →

Today we’ll be tackling one of the most confounding and troubling trends in modern medicine. Scientific studies have confirmed again and again that for many ailments and conditions, dietary changes … Continue Reading →

This month’s bulletin kicks off with a study that digs into one of the genetic differences associated with having XX vs XY chromosomes. You’ll learn about an epigenetic modulator that … Continue Reading →

A study led by the University of Bristol in the UK has found that the mechanism of action of the osteoporosis drug romosozumab (Evenity) increases the risk of heart attack … Continue Reading →

In this month’s Bulletin, we highlight the continued influence of Big Pharma on the Medical Establishment, yet there are also encouraging signs of a more natural approach to achieving wellness. … Continue Reading →

This month, we bring you three recent studies, all about healthcare choices that are (or may soon be) available. First, you’ll hear about the latest attempt to create a new … Continue Reading →

Many commonly prescribed medications cause bone loss and can lead to osteoporosis. Furthermore, doctors are often unaware that the drugs they prescribe can have this effect. Once again, it’s incumbent … Continue Reading →

Making health decisions often comes down to a calculation of risk. It is the measurement of the likelihood of a negative outcome, like a disease or a fracture. Risk is … Continue Reading →